The Latest Cardiac and Vascular News
Study Presented at the International Society for Heart and Lung Transplant 42nd Annual Meeting and Scientific Sessions 2022 Oak Ridge, TN, May 02, 2022 (GLOBE NEWSWIRE) — Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, announces new data validating the benefits of the Company’s BVA-100 blood test (BVA) in improving survival for advanced heart failure […]
PARIS–(BUSINESS WIRE)–CorWave, a French medical device company committed to the fight against heart failure, announced that it has successfully completed the first 90-day preclinical study to evaluate its left ventricular assist device (LVAD) operating synchronously with the native heart without the use of sensors. The results were presented at the American Society for Artificial Internal […]
WEBSTER, Texas, Dec. 16, 2020 /PRNewswire/ — Corvion – developer of fully implanted mechanical circulatory support devices – announced today that it has received Breakthrough Device Designation for its fully implanted Left Ventricular Assist Device (LVAD) from the FDA. The designation will allow the company to interact with the FDA’s experts to efficiently address topics as they […]
City’s first successful Mechanical device implant on heart gives new lease of life to a Yemeni National PUNE, India, Feb. 17, 2020 /PRNewswire/ — Sahyadri Super Speciality Hospital, Deccan recently conducted a rare and high risk left ventricular assist device implantation (LVAD) procedure on a 22-year-old Yemeni National who was suffering from end stage heart failure. A […]
DUBLIN, Oct. 29, 2019 (GLOBE NEWSWIRE) — Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has received Breakthrough Device designation from the U.S. Food and Drug Administration (FDA) for the Medtronic Fully Implantable Left Ventricular Assist Device (LVAD) for patients with advanced heart failure, currently in development. Currently, LVAD systems include an […]
CLICHY, France–(BUSINESS WIRE)–CorWave announced that it successfully completed its first 60-day preclinical study to evaluate its Left Ventricular Assist Device (LVAD). The results were presented at the 46th Annual Conference of the European Society for Artificial Organs (ESAO) in Hannover. Trevor Snyder, PhD, Senior Director, Translational and Clinical Research at CorWave, delivered an oral presentation, “CorWave […]
CLICHY, France–(BUSINESS WIRE)–CorWave announced today that results from chronic preclinical studies to evaluate its Left Ventricular Assist Device (LVAD) will be presented at the 65th Annual Conference of the American Society for Artificial Internal Organs (ASAIO) in San Francisco. The poster presentation, entitled “Low Shear, High Flow, and Physiologic Pulsatility: The CorWave LVAD”, is part […]
WASHINGTON, June 24, 2019 /PRNewswire/ — The Centers for Medicaid and Medicare Services last Friday issued their final National Coverage Decision on how hospitals will be approved to do the TAVR (transaortic valve replacement) procedure, a less invasive valve replacement treatment that avoids open heart surgery and allows patients to resume daily life more quickly. “CMS’s decision to […]
Orlando, Florida, April 03, 2019 (GLOBE NEWSWIRE) — The Journal of Heart and Lung Transplantation is releasing its themed issue on Mechanical Circulatory Support to coincide with the 39th Annual Meeting of the International Society for Heart and Lung Transplantation being held April 3 – 6 in Orlando, Florida. This special issue highlights several innovations, multicenter trials and […]
NEW YORK and MELBOURNE, Australia, March 26, 2019 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in cellular medicines for inflammatory diseases, today announced that the International Center for Health Outcomes and Innovation Research (InCHOIR) at the Icahn School of Medicine at Mount Sinai and Mesoblast have entered into a Memorandum of Understanding (MOU) […]
